2-(4-Chlorophenyl)-1-[(3,4-dichlorophenyl)methoxy]-1H-1,3-benzodiazole

Catalog No. :
ACNETT231
CAS No. :
338791-31-4
Molecular Formula :
C20H13Cl3N2O
Molecular Weight :
403.70

IUPAC Name:2-(4-chlorophenyl)-1-((3,4-dichlorobenzyl)oxy)-1H-benzo[d]imidazole

2-(4-Chlorophenyl)-1-[(3,4-dichlorophenyl)methoxy]-1H-1,3-benzodiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chlorophenyl)-1-[(3,4-dichlorophenyl)methoxy]-1H-1,3-benzodiazole
IUPAC Name2-(4-chlorophenyl)-1-((3,4-dichlorobenzyl)oxy)-1H-benzo[d]imidazole
MDL No.MFCD00141125
Molecular FormulaC20H13Cl3N2O
Molecular Weight403.70
SMILESClC1=CC=C(CON2C(C3=CC=C(Cl)C=C3)=NC4=CC=CC=C42)C=C1Cl
InChI KeyDMDWGMJXNKKJOT-UHFFFAOYSA-N
Synonym2-(4-CHLOROPHENYL)-1-[(3,4-DICHLOROBENZYL)OXY]-1H-1,3-BENZIMIDAZOLE;2-(4-chlorophenyl)-1-[(3,4-dichlorophenyl)methoxy]-1H-1,3-benzodiazole;1H-Benzimidazole, 2-(4-chlorophenyl)-1-[(3,4-dichlorophenyl)methoxy]-
CAS No.338791-31-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNETT231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNETT231 route product structure diagram
    ACNETT231338791-31-4
Inquiry

2. ACNETT231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNETT231 route product structure diagram
    ACNETT231338791-31-4
Inquiry

Comments (0)